News / Taiwan / cnyes
ABC-KY August Revenue Surges 64% YoY, Outperforming Biotech Sector
Health Technology · Biotechnology · cnyes · 2026-09-10
6598
ABC-KY reported August 2026 revenue of NT$60.94 million, marking a 64% year-over-year increase, with year-to-date growth reaching 70.27%.
What Happened
Revenue Growth: ABC-KY announced its August 2026 revenue reached NT$60.94 million, representing a significant year-over-year increase of 64% and a month-over-month rise of 32.61%.
Year-to-Date Performance: The cumulative revenue for the first eight months of 2026 stands at NT$535 million, reflecting a robust year-to-date growth rate of 70.27%.
Market Performance: The stock is currently trading at NT$28.8, with a 1.79% gain over the past five days, outperforming the broader biotech sector which saw a decline of 1.57%.
Business Overview: ABC-KY operates within the biotechnology sector, specializing in the research, development, and sales of automated multi-testing instruments and reagents.